These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30273913)

  • 21. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
    Zawilska JB; Andrzejczak D
    Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New drugs of abuse.
    Rech MA; Donahey E; Cappiello Dziedzic JM; Oh L; Greenhalgh E
    Pharmacotherapy; 2015 Feb; 35(2):189-97. PubMed ID: 25471045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging Agents of Substance Use/Misuse.
    Michienzi AE; Borek HA
    Emerg Med Clin North Am; 2022 May; 40(2):265-281. PubMed ID: 35461623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New psychoactive substances of natural origin: A brief review.
    Feng LY; Battulga A; Han E; Chung H; Li JH
    J Food Drug Anal; 2017 Jul; 25(3):461-471. PubMed ID: 28911631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic cannabinoid use disorder: an update for general psychiatrists.
    Grigg J; Manning V; Arunogiri S; Lubman DI
    Australas Psychiatry; 2019 Jun; 27(3):279-283. PubMed ID: 30663326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The behavioral profile of spice and synthetic cannabinoids in humans.
    Müller HH; Kornhuber J; Sperling W
    Brain Res Bull; 2016 Sep; 126(Pt 1):3-7. PubMed ID: 26548494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug abuse in Asia.
    Suwanwela C; Poshyachinda V
    Bull Narc; 1986; 38(1-2):41-53. PubMed ID: 3535959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential neonatal toxicity of new psychoactive substances.
    Fujiwara R; Journey M; Al-Doori F; Bell P; Judge B; Miracle K; Ito K; Jones S
    Pharmacol Ther; 2023 Aug; 248():108468. PubMed ID: 37290575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths.
    Caloro M; Calabrò G; Kotzalidis GD; Cuomo I; Corkery JM; Vento AE; Lionetto L; De Filippis S; Ranieri V; Lonati D; Locatelli CA; de Pisa E; Di Tommaso A; Girardi P; Schifano F
    Addict Behav; 2016 Sep; 60():53-7. PubMed ID: 27088514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthetic cannabinoids: A new addiction matrix].
    Scocard A; Benyamina A; Coscas S; Karila L
    Presse Med; 2017 Jan; 46(1):11-22. PubMed ID: 28063756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do police arrestees substitute legal highs for other drugs?
    Wilkins C; Parker K; Prasad J; Jawalkar S
    Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
    Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM
    Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
    Heikman P; Sundström M; Pelander A; Ojanperä I
    Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    Singh D; Müller CP; Vicknasingam BK
    Drug Alcohol Depend; 2014 Jun; 139():132-7. PubMed ID: 24698080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
    Fattore L
    Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phantom menace: novel psychoactive substances and the UK Armed Forces.
    Hunter AH; Ayres T; Moreland N; Cox A
    J R Army Med Corps; 2018 Nov; 164(6):450-457. PubMed ID: 29934414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids.
    Vučinić S; Kilibarda V; Đorđević S; Đorđević D; Perković-Vukčević N; Vuković-Ercegović G; Antonijević B; Ćurčić M; Antonijević E; Brajković G
    Arh Hig Rada Toksikol; 2018 Jun; 69(2):178-185. PubMed ID: 29990297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.